Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;15(9):667-683.
doi: 10.1080/20415990.2024.2379756. Epub 2024 Aug 5.

A novel liposomal formulation for ocular delivery of caspofungin: an experimental study by quality by design-based approach

Affiliations

A novel liposomal formulation for ocular delivery of caspofungin: an experimental study by quality by design-based approach

Mercy Macwan et al. Ther Deliv. 2024.

Abstract

Aim: This study focuses on the development of a Caspofungin liposome for efficient ocular delivery by enhancing corneal penetration.Method: Quality by design (QbD) approach was adopted to identify critical factors that influence final liposomal formulation. The liposome developed using thin film hydration after optimization was subjected to characterization for physicochemical properties, irritation potential and corneal uptake.Results: The numerical optimization suggests an optimal formulation with a desirability value of 0.706, using CQAs as optimization goals with 95% prediction intervals. The optimized formulation showed no signs of irritation potential along with observation of significant corneal permeation.Conclusion: The liposomal formulation increased the permeability of Caspofungin, which could enhance the efficacy for the treatment of conditions, like fungal keratitis.

Keywords: Caspofungin; echinocandins; fungal keratitis; liposome; ocular delivery; quality by design.

Plain language summary

[Box: see text].

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, stock ownership or options and expert testimony.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Response surface plots generated using box-behnken design to indicate the impact of independent factors on %Encapsulation efficiency (%EE) (A), %drug release at 2 h (Q2) (B), %drug release at 8 h (Q8) (C), time required to release 90% of drug (t90) (D), vesicle size (E) and Polydispersity index (PDI) (F).
Figure 2.
Figure 2.
Morphological Studies of the Csp-liposomes. (A) Transmission electron microscopic (TEM) image of Csp-liposome particles (Scale = 200 nm); (B) Transmission Electron Microscopic (TEM) image with magnified view of liposomes (Scale = 100 nm); (C) Scanning Electron Microscopic (SEM) photographs of Csp-liposomes (Scale = 200 nm; Average size <100 nm).
Figure 3.
Figure 3.
In vitro drug release of liposomal formulation. Data are presented as Mean ± SD (n = 3).
Figure 4.
Figure 4.
Ocular irritation study of Csp-liposome. (A) Vascular responses of Chorioallantoic Membrane (CAM) surface treated with 0.9% NaCl, 1%SDS, 0.1N NaOH and Optimized Caspofungin (Csp)-liposome formulation. (B) Cumulative Irritation score in Hen's Egg Chorioallantoic Membrane Test (HET-CAM) test. Results are expressed as mean ± SD, n = 3.
Figure 5.
Figure 5.
Ex vivo transcorneal permeation of Csp-liposome. (A) Ex vivo transcorneal permeation of optimized Caspofungin (Csp)-liposomes and Caspofungin (Csp) solution in STF (pH 7.4) at 37°C. Confocal laser scanning microscopy (CLSM) images of (B) Liposome bright field, (C) detection of fluoroscein isothiacyanate (FITC) labeled liposome.

Similar articles

References

    1. Reginatto P, Agostinetto GdJ, Fuentefria RdN, et al. Eye fungal infections: a mini review. Arch Microbiol. 2023;205(6):236. doi: 10.1007/s00203-023-03536-6 - DOI - PMC - PubMed
    1. Sharma N, Bagga B, Singhal D, et al. Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes. Ocul Surf. 2022;24:22–30. doi: 10.1016/j.jtos.2021.12.001 - DOI - PubMed
    1. Maharana PK, Sharma N, Nagpal R, et al. Recent advances in diagnosis and management of mycotic keratitis. 2016;64(5):346–357. doi: 10.4103/0301-4738.185592 - DOI - PMC - PubMed
    1. Bakken IM, Jackson CJ, Utheim TP, et al. The use of in vivo confocal microscopy in fungal keratitis – Progress and challenges. Ocul Surf. 2022;24:103–118. doi: 10.1016/j.jtos.2022.03.002 - DOI - PubMed
    1. Klotz SA, Penn CC, Negvesky GJ, et al. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13(4):662–685. doi: 10.1128/cmr.13.4.662 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources